logoTry Persana

Rejuvenation Technologies Inc. - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Rejuvenation Technologies Inc. including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Rejuvenation Technologies Inc. company logo

Advanced therapeutics to extend the healthspan.

Rejuvenation Technologies is a biotechnology company specializing in developing RNA drug candidates to reverse mechanisms of aging, aiming to prevent or delay age-related diseases through molecular rejuvenation.

HeadquartersMountain View, United States
Team size11-50
Founded2018

What is Rejuvenation Technologies Inc.? - Company Overview & Details

Rejuvenation Technologies Inc. is Rejuvenation Technologies is a biotechnology company specializing in developing RNA drug candidates to reverse mechanisms of aging, aiming to prevent or delay age-related diseases through molecular rejuvenation. Founded in 2018, the company is headquartered in Mountain View, United States.

Who Founded Rejuvenation Technologies Inc.?

Rejuvenation Technologies Inc. was founded by John Ramunas.

Who are the Key Executives at Rejuvenation Technologies Inc.? - Leadership Team

Rejuvenation Technologies Inc. is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Rejuvenation Technologies Inc.

John RamunasCEO

Chief Technology Officer (CTO) of Rejuvenation Technologies Inc.

CTO

About John Ramunas - CEO of Rejuvenation Technologies Inc.

John Ramunas serves as the Chief Executive Officer of Rejuvenation Technologies Inc., leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Rejuvenation Technologies Inc. Company Details & Key Information

Where is Rejuvenation Technologies Inc. located?

Rejuvenation Technologies Inc. is headquartered in Mountain View, United States.

How many employees does Rejuvenation Technologies Inc. have?

Rejuvenation Technologies Inc. has 11-50 employees.

When was Rejuvenation Technologies Inc. founded?

Rejuvenation Technologies Inc. was founded in 2018.

Rejuvenation Technologies Inc. Official Website

How much funding has Rejuvenation Technologies Inc. raised?

Rejuvenation Technologies Inc. has raised $15.2 Million across 9 funding rounds. The most recent funding was completed on 2023-10-06.

Funding Overview

Rejuvenation Technologies has raised a total of $15.2 million across funding rounds to develop its innovative RNA therapeutics targeting age-related diseases.

$15.2 Million
Total Funding Raised
9
Funding Rounds
2023-10-06
Latest Round

Rejuvenation Technologies Inc. Funding History

Seed
2023-09-06
$10.6 Million
Series Unknown
2023-11-11

Who are the key investors in Rejuvenation Technologies Inc.?

Rejuvenation Technologies Inc. is backed by 1 key investors including Khosla Ventures. These investors focus on Biotechnology, Longevity, Healthcare sectors.

Rejuvenation Technologies Inc. Investor Overview

1
Key Investors
3
Focus Areas
2
Notable Investments

Complete List of Rejuvenation Technologies Inc. Investors

Khosla Ventures

A major venture capital firm focusing on early-stage technology companies.

Investment Focus
Biotechnology
Longevity
Healthcare
Notable Portfolio Companies
Rejuvenation Technologies Inc.
Research and Treatments in Longevity

What sectors do Rejuvenation Technologies Inc. investors focus on?

The investors backing Rejuvenation Technologies Inc. primarily focus on Biotechnology, Longevity, Healthcare sectors.

Biotechnology
Longevity
Healthcare

Featured Investor: Khosla Ventures

Khosla Ventures

A major venture capital firm focusing on early-stage technology companies.

Notable Investments: Rejuvenation Technologies Inc., Research and Treatments in Longevity

What are Rejuvenation Technologies Inc.'s future plans?

Rejuvenation Technologies Inc. Rejuvenation Technologies plans to advance its RNA therapies to clinical trials and expand its team.

Rejuvenation Technologies Inc. Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Rejuvenation Technologies Inc. face?

Rejuvenation Technologies Inc. has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Rejuvenation Technologies Inc.

1

Difficulty in mRNA delivery

2

Competition in the biotech space

What opportunities does Rejuvenation Technologies Inc. have?

Rejuvenation Technologies Inc. has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Rejuvenation Technologies Inc.

1

Growing interest in aging technologies

2

Rising demand for anti-aging treatments

Rejuvenation Technologies Inc. Strategic Position Summary

Key Focus Areas

Rejuvenation Technologies Inc. is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Rejuvenation Technologies Inc.?

Rejuvenation Technologies Inc. has 2 recent news updates covering key business developments and market activities.

Rejuvenation Technologies Inc. News Overview

2
Recent Articles
Active
Media Coverage
2023-10-06
Latest Update

What is Rejuvenation Technologies Inc. in the news for?

Rejuvenation Technologies Inc. is currently featured in news for Rejuvenation Technologies Inc. received financing of $15M in funding on Oct 6th '23. and other significant business developments.

Recent News Articles About Rejuvenation Technologies Inc.

Article 1
2023-10-06

Rejuvenation Technologies Inc. received financing of $15M in funding on Oct 6th '23.

California-based Rejuvenation Technologies raised over $15 million to pioneer anti-aging techniques targeting telomere shortening.

yahoo.com
Read News
Article 2
2024-01-04

Rejuvenation Technologies Inc. is developing RNA drug candidates on Jan 4th '24.

Rejuvenation Technologies and Kudo Biotechnology have entered an agreement to develop RNA drug candidates.

kudobio.com
Read News

Rejuvenation Technologies Inc. FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Rejuvenation Technologies Inc. including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Rejuvenation Technologies Inc. Questions & Answers - Company Information

Q1

What is Rejuvenation Technologies Inc.?

Rejuvenation Technologies is a biotechnology company specializing in developing RNA drug candidates to reverse mechanisms of aging, aiming to prevent or delay age-related diseases through molecular rejuvenation.

Q2

Who founded Rejuvenation Technologies Inc.?

Rejuvenation Technologies Inc. was founded by John Ramunas.

Q3

Who is the CEO of Rejuvenation Technologies Inc.?

The CEO of Rejuvenation Technologies Inc. is John Ramunas. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Rejuvenation Technologies Inc. raised?

Rejuvenation Technologies Inc. has raised a total of $$15.2 Million across 9 funding rounds. The most recent funding was completed on 2023-10-06.

Q5

Who are the investors in Rejuvenation Technologies Inc.?

Rejuvenation Technologies Inc.'s key investors include Khosla Ventures.

Q6

Where is Rejuvenation Technologies Inc. headquartered?

Rejuvenation Technologies Inc. is headquartered in Mountain View, United States.

Q7

When was Rejuvenation Technologies Inc. founded?

Rejuvenation Technologies Inc. was founded in 2018.

Q8

How many employees does Rejuvenation Technologies Inc. have?

Rejuvenation Technologies Inc. has 11-50 employees.

Q9

What is Rejuvenation Technologies Inc.'s official website?

You can visit Rejuvenation Technologies Inc.'s official website at http://rejuvenationtech.com.

Q10

What was Rejuvenation Technologies Inc.'s latest funding round?

Rejuvenation Technologies Inc.'s latest funding round was a Seed round of $$10.6 Million completed on 2023-09-06.

Q11

Who is founder?

John Ramunas

Q12

What does the company do?

Rejuvenation Technologies develops RNA drug candidates to reverse mechanisms of aging and prevent or delay age-related diseases.

Q13

How much funding?

$15.2 Million

Q14

Latest funding date?

2023-10-06

Q15

Who are the investors?

Khosla Ventures

Q16

What are the challenges?

Difficulty in mRNA delivery Competition in the biotech space

Q17

What are the opportunities?

Growing interest in aging technologies Rising demand for anti-aging treatments

Q18

Latest news?

California-based Rejuvenation Technologies raised over $15 million to pioneer anti-aging techniques targeting telomere shortening. Rejuvenation Technologies and Kudo Biotechnology have entered an agreement to develop RNA drug candidates.

More Information About Rejuvenation Technologies Inc.

For additional details about Rejuvenation Technologies Inc., including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.